Geodon: Effective Atypical Antipsychotic for Schizophrenia and Bipolar Disorder
Geodon
| Product dosage: 20mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 20 | $2.70 | $54.00 (0%) | 🛒 Add to cart |
| 30 | $1.90 | $81.00 $57.00 (30%) | 🛒 Add to cart |
| 60 | $1.42 | $162.00 $85.00 (48%) | 🛒 Add to cart |
| 90 | $1.19 | $243.00 $107.00 (56%) | 🛒 Add to cart |
| 120 | $0.95 | $324.00 $114.00 (65%) | 🛒 Add to cart |
| 180 | $0.86 | $486.00 $154.00 (68%) | 🛒 Add to cart |
| 270 | $0.80 | $729.00 $216.00 (70%) | 🛒 Add to cart |
| 360 | $0.76
Best per pill | $972.00 $274.00 (72%) | 🛒 Add to cart |
| Product dosage: 40mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $4.60 | $46.00 (0%) | 🛒 Add to cart |
| 20 | $3.15 | $92.00 $63.00 (32%) | 🛒 Add to cart |
| 30 | $2.20 | $138.00 $66.00 (52%) | 🛒 Add to cart |
| 60 | $1.58 | $276.00 $95.00 (66%) | 🛒 Add to cart |
| 90 | $1.37 | $414.00 $123.00 (70%) | 🛒 Add to cart |
| 120 | $1.27 | $552.00 $152.00 (72%) | 🛒 Add to cart |
| 180 | $1.21 | $828.00 $218.00 (74%) | 🛒 Add to cart |
| 270 | $1.18 | $1242.00 $319.00 (74%) | 🛒 Add to cart |
| 360 | $1.16
Best per pill | $1656.00 $418.00 (75%) | 🛒 Add to cart |
Geodon (ziprasidone) is an atypical antipsychotic medication designed to provide comprehensive management of psychiatric conditions with a favorable side effect profile. It works by balancing key neurotransmitters in the brain, offering both antipsychotic and mood-stabilizing properties. Clinically proven for the treatment of schizophrenia and acute manic or mixed episodes associated with bipolar disorder, Geodon provides reliable symptom control while minimizing certain metabolic risks commonly associated with other agents in its class. Its unique receptor binding profile supports both efficacy and tolerability, making it a valuable option in long-term psychiatric care.
Features
- Active ingredient: Ziprasidone hydrochloride
- Available in oral capsules (20 mg, 40 mg, 60 mg, 80 mg) and intramuscular injection formulations
- Dual action on serotonin (5-HT2A) and dopamine (D2) receptors
- FDA-approved for schizophrenia and bipolar I disorder
- Low incidence of weight gain and metabolic changes compared to other antipsychotics
- Requires administration with food for optimal absorption
Benefits
- Reduces positive and negative symptoms of schizophrenia, such as hallucinations, delusions, and social withdrawal
- Stabilizes mood rapidly during acute manic or mixed episodes in bipolar disorder
- Lower risk of significant weight gain, dyslipidemia, or glucose intolerance
- Flexible dosing allows for individualized treatment regimens
- Intramuscular formulation offers rapid control of agitation in emergency settings
- May improve overall functioning and quality of life in chronic psychiatric illness
Common use
Geodon is primarily indicated for the treatment of schizophrenia in adults, helping to manage both acute episodes and maintenance therapy. It is also approved for the treatment of acute manic or mixed episodes associated with bipolar I disorder, as either monotherapy or as an adjunct to lithium or valproate. Off-label uses may include adjunctive treatment in major depressive disorder and agitation related to dementia, though these are not FDA-approved indications. Treatment should always be initiated under the supervision of a healthcare provider experienced in managing psychiatric conditions.
Dosage and direction
For schizophrenia, the recommended initial oral dose is 20 mg twice daily, taken with at least 500 calories of food to enhance absorption. Dosage may be increased gradually, at intervals of no less than two days, up to a maximum of 80 mg twice daily based on tolerability and clinical response. For bipolar mania, the starting dose is 40 mg twice daily with food, increasing to 60 or 80 mg twice daily as needed. Intramuscular dosing for acute agitation is 10–20 mg, which may be repeated every four hours up to a maximum of 40 mg per day. Dosage adjustments are necessary in special populations, including the elderly and those with hepatic impairment.
Precautions
Patients should be monitored for signs of tardive dyskinesia, neuroleptic malignant syndrome, and QT prolongation. Regular ECG monitoring is advised in patients with known cardiovascular disease or those taking other QT-prolonging drugs. Geodon may impair judgment, thinking, or motor skills; caution is advised when driving or operating machinery. Elderly patients with dementia-related psychosis treated with antipsychotics are at an increased risk of death. Glucose and lipid levels should be monitored periodically due to potential metabolic effects, albeit lower than with some other antipsychotics.
Contraindications
Geodon is contraindicated in patients with a known hypersensitivity to ziprasidone or any component of the formulation. It should not be used in combination with other drugs known to prolong the QT interval, such as quinidine, sotalol, or certain antipsychotics and antibiotics. Use is also contraindicated in patients with a history of QT prolongation, recent myocardial infarction, or uncompensated heart failure. Concomitant use with CYP3A4 inhibitors like ketoconazole is contraindicated due to increased ziprasidone exposure.
Possible side effect
Common side effects include somnolence, nausea, constipation, dizziness, and akathisia. Extrapyramidal symptoms such as dystonia or parkinsonism may occur. Less frequently, orthostatic hypotension, rash, or weight gain may be observed. QT prolongation on ECG has been reported, though the clinical significance varies. Rare but serious adverse events include neuroleptic malignant syndrome, tardive dyskinesia, and seizures. Injection-site pain may occur with intramuscular administration.
Drug interaction
Geodon is metabolized primarily by CYP3A4; coadministration with strong inhibitors (e.g., ketoconazole) increases ziprasidone levels and is contraindicated. Inducers of CYP3A4 (e.g., carbamazepine) may reduce its efficacy. Concomitant use with other central nervous system depressants, including alcohol, may enhance sedative effects. Due to QT-prolonging potential, avoid use with other drugs that prolong QT interval, such as certain antiarrhythmics, macrolide antibiotics, and antidepressants. Antihypertensive agents may potentiate orthostatic hypotension.
Missed dose
If a dose is missed, it should be taken as soon as possible unless it is nearly time for the next scheduled dose. In that case, skip the missed dose and resume the regular dosing schedule. Do not double the dose to make up for a missed one. Consistent daily administration is important to maintain stable plasma concentrations and therapeutic effect.
Overdose
Symptoms of overdose may include sedation, hypotension, and QT prolongation. In cases of suspected overdose, provide supportive care including continuous ECG monitoring to detect potential arrhythmias. There is no specific antidote for ziprasidone overdose; management should focus on symptomatic treatment and maintaining vital functions. Gastric lavage or administration of activated charcoal may be considered if ingestion was recent. Contact a poison control center for further guidance.
Storage
Store Geodon capsules at room temperature (20–25°C or 68–77°F), in a tightly closed container, and protect from light and moisture. Keep out of reach of children and pets. Do not use beyond the expiration date printed on the packaging. The intramuscular formulation should be stored in its original packaging and protected from light until use.
Disclaimer
This information is intended for educational purposes only and does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting or changing any medication regimen. Individual patient responses may vary, and only a licensed practitioner can determine the appropriate use of Geodon based on a comprehensive clinical evaluation.
Reviews
Clinical trials and post-marketing studies have demonstrated Geodon’s efficacy in reducing symptoms of schizophrenia and bipolar mania, with particular praise for its metabolic profile. Many experts note its utility in patients concerned about weight gain or glucose intolerance. Some reports cite tolerability issues such as akathisia or sedation, though these are often manageable with dose adjustment. Overall, Geodon is regarded as a effective option within the atypical antipsychotic class, especially for patients requiring long-term therapy with minimal metabolic impact.